RESUMEN
Two hundred and thirty-three blood samples of water buffalo were collected on four farms in Veracruz state and Tabasco state, Mexico, to detect and confirm the identities of Babesia and Anaplasma spp. sequences. Nested PCR assays were used for the amplification of specific genes encoding B. bovis rhoptry-associated protein (RAP-1), B. bigemina SpeI-AvaI restriction fragment, and Anaplasma marginale major surface protein 5 (MSP5). Using DNA sequencing and BLASTn analysis for DNA homology hemoparasite identification, the identities of the hemoparasites were established by comparing the nucleotide sequences obtained in this study with those available in the GenBank database at the National Center for Biotechnology Information (NCBI). Water buffalo infection with at least one of the hemoparasites under study was detected in 45% (105/233) of the blood samples, while a mixed infection with B. bovis and B. bigemina was detected in 6.4% (15/233) of samples. For this cross-sectional study, mixed infections with the three hemoparasites were not detected. BLASTn analysis revealed that the nucleotide sequences of the water buffalo isolates shared sequence identity values ranging from 88 to 100% with previously published gene sequences of B. bovis, B. bigemina, and A. marginale. The current results confirm that water buffalo, as cattle, are also carriers of hemoparasite infections that are tick-transmitted, and suggest that they probably have an important role in the epidemiology of bovine babesiosis in Mexico.
RESUMEN
The indirect fluorescent antibody test (IFAT) is the most frequently used test to conduct seroepidemiological studies so far, and it is regarded as the "gold standard" test for the serological diagnosis of bovine babesiosis. The aim of the present study was to compare the enzyme-linked immunosorbent assay (ELISA) and the rapid immunochromatography test (ICT) for use in the serological diagnosis of cattle exposed to B. bovis in Mexico. The evaluation of test performance was carried out with 30 positive and 30 negative reference sera. A total of 72 bovine sera samples collected from cattle in a region with endemic bovine babesiosis were analyzed by ELISA and ICT, and the results were compared with those of IFAT. Kappa value (k) was also calculated to determine the agreement between tests. The sensitivity and specificity of ELISA for detecting antibodies against B. bovis were 87% (26/30) and 80% (24/30), respectively. The sensitivity and specificity of ICT for detecting antibodies against B. bovis were 90% (27/30) and 83.3% (25/30), respectively. The overall concordance determined for ELISA and ICT was 94.4% (68/72) and 98.6% (71/72), respectively, when the results were compared with those of IFAT. ICT was more sensitive and specific in this comparative study, showing good strength of agreement (k = 0.79) with respect to IFAT. ICT combines a strip-based assay system that is fast, practical, and sensitive for detection of antibodies to B. bovis, which suggests that it could be applied in the field without requiring any laboratory equipment for its use and interpretation of test results.
RESUMEN
An attenuated live vaccine containing Babesia bovis and B. bigemina cultured in vitro with a serum-free medium was assessed for its clinical protection conferred of naïve cattle, under natural tick-challenge in a high endemicity zone to Babesia spp. Three groups of six animals were treated as follows: group I (GI) received a vaccine derived from parasites cultured with a free-serum medium; group II (GII) were immunized with the standard vaccine, with parasites cultured in a medium supplemented with 40% (v/v) bovine serum; and a control group (GIII) inoculated with non-infected bovine erythrocytes. Inocula were administered by IM route. Experimental animals were kept during 23days after vaccination in a cattle farm free of ticks and Babesia spp. Thereafter, cattle were moved to a high endemicity farm for natural exposure to Babesia spp. transmitted by Rhipicephalus microplus ticks. Protection against clinical babesiosis was observed in bovines belonging to GI (100%) and GII (83.33%), while the control animals (GIII) were not protected, and showed severe clinical signs, closely related to babesiosis, were observed for at least three consecutive days during the challenge. These were fever, anemia, which were measured simultaneously, and circulating parasites were detected by optic light microscopy. All cattle showed B. bovis and B. bigemina in stained blood films during the challenge; B. bovis antibody titers were higher than those to B. bigemina in GI and GII, and lower titers were determined in GIII. The protective capacity of the vaccine derived from B. bovis and B. bigemina cultured in vitro in a serum-free medium was demonstrated.
Asunto(s)
Babesia bovis/inmunología , Babesia/inmunología , Babesiosis/prevención & control , Vacunas Atenuadas/administración & dosificación , Anemia/parasitología , Animales , Anticuerpos Antiprotozoarios/sangre , Babesia/crecimiento & desarrollo , Babesia/ultraestructura , Babesia bovis/crecimiento & desarrollo , Babesia bovis/ultraestructura , Babesiosis/sangre , Babesiosis/inmunología , Babesiosis/transmisión , Bovinos , Medio de Cultivo Libre de Suero , Fiebre/parasitología , Microscopía , Rhipicephalus/parasitología , Temperatura de Transición , Vacunación/métodos , Vacunas Atenuadas/inmunologíaRESUMEN
The effect of Lactobacillus casei administered along with a live attenuated vaccine vs. bovine babesiosis (VAC) on induction of IgG1 and IgG2 antibodies to Babesia bovis and Babesia bigemina was assessed by the indirect fluorescent antibody test (IFAT) in bovines of an endemic babesiosis area before (day 0) and after vaccination (days 15 and 30). We previously reported that L. casei increases the efficiency of VAC under controlled conditions and under extreme conditions in the field; however, the levels of IgG1 and IgG2 antibodies to B. bovis and B. bigemina are not known in vaccinated animals. Twenty-one dairy cows were allocated into three groups (seven animals per group): unvaccinated, vaccinated with VAC and vaccinated simultaneously with VAC and L. casei (VAC-LC). All animals were kept in a babesiosis endemic area at Tlalixcoyan, Veracruz. At days 15 and 30 after vaccination, the average levels of IgG1 to B. bovis and to B. bigemina were significantly higher in VAC-LC group than levels observed in VAC and control groups (P<0.01). Levels of IgG2 were similar in VAC and VAC-LC groups but higher than in the control group (P<0.01). When tested in in vitro cultures of B. bovis, sera from VAC-LC group significantly inhibited parasite growth as compared with the sera of the other two groups. It is suggested that the efficiency improvement of VAC, in part, is due to the L. casei boost of IgG1 over IgG2 antibodies to B. bovis and B. bigemina when the bacteria is co-inoculated with this vaccine.
Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Babesia/inmunología , Babesiosis/prevención & control , Enfermedades de los Bovinos/prevención & control , Lacticaseibacillus casei/inmunología , Vacunas Antiprotozoos/administración & dosificación , Animales , Babesia bovis/inmunología , Babesiosis/inmunología , Babesiosis/parasitología , Bovinos , Enfermedades de los Bovinos/inmunología , Enfermedades de los Bovinos/parasitología , Femenino , Técnica del Anticuerpo Fluorescente Indirecta/veterinaria , Inmunoglobulina G/sangre , Vacunación , Vacunas AtenuadasRESUMEN
The effect of Lactobacillus casei on INIFAP's mixed vaccine against bovine babesiosis (VAC) was assessed in bovines in an endemic babesiosis area. It was previously reported that L. casei increases the efficiency of the Mexican mixed vaccine against bovine babesiosis under controlled conditions. The results of the present study demonstrated the effectiveness of simultaneous vaccination of bovines with L. casei and the mixed vaccine against bovine babesiosis in eliciting a protective immune response under extreme conditions in the field. Twenty Babesia spp free bovines were allocated into three groups: un-vaccinated (Control, n = 9), vaccinated with VAC (n = 5), and vaccinated simultaneously with VAC and Lactobacillus casei (LC-VAC, n = 6). All animals were kept in a tick and Babesia spp free field at Coatepec, Veracruz during 24 days before moving them to Paso del Toro, Veracruz, for a natural exposition to Babesia spp transmitted by Riphicephalus (Boophilus) microplus ticks. Protection against Babesia spp was observed in bovines belonging to VAC and LC-VAC groups, while control animals showed severe clinical babesiosis. Bovines in VAC-LC group showed less clinical signs between days 12-16 after challenge as compared with animals in VAC group. All bovines showed both Babesia spp after challenge. Levels of IgG anti-Babesia in animals from both vaccinated groups, determined by indirect immunofluorescence test, always were higher to Babesia bovis than to B. bigemina after vaccination and challenge. It was demonstrated the efficiency of simultaneous vaccination of bovines with VAC and L. casei, in eliciting a better protective immune response against naturally transmitted Babesia spp under extreme field conditions.
Se evaluó el efecto de Lactobacillus casei en la vacuna mixta contra babesiosis bovina del INIFAP (VAC), en bovinos de un área endémica de babesiosis. Previamente se informó que L. casei incrementa la eficacia de la vacuna mixta mexicana contra babesiosis bovina bajo condiciones controladas. Los resultados aquí expuestos demostraron dicha efectividad para generar una respuesta inmunitaria protectora bajo condiciones extremas en el campo. Veinte bovinos libres de Babesia spp fueron distribuidos al azar en tres grupos: testigo no vacunado (Testigo, n = 9), vacunado con VAC (n = 5), y vacunado simultáneamente con VAC y L. casei (LC-VAC, n = 6). Todos los animales se mantuvieron en un corral libre de garrapatas y Babesia spp en Coatepec, Veracruz durante 24 días antes de transportarlos a Paso del Toro, Veracruz, para una exposición natural a Babesia spp transmitida por garrapatas Riphicephalus (Boophilus). Se observó protección contra Babesia spp en bovinos pertenecientes a los grupos VAC y LC-VAC, mientras que los animales testigo mostraron signos clínicos de babesiosis aguda. Los bovinos del grupo VAC-LC mostraron menos signos clínicos que los del grupo VAC entre los días 12-16. Todos los bovinos mostraron Babesia spp después de la confrontación. Los niveles de IgG anti-Babesia en los animales de los grupos vacunados, determinados por inmunofluorescencia indirecta, siempre fueron más elevados contra Babesia bovis que contra B. bigemina después de la vacunación y de la confrontación. Se demostró la eficacia de la vacunación simultánea con VAC y L. casei en bovinos, para generar una mejor respuesta inmunitaria protectora contra Babesia spp transmitida naturalmente por garrapatas, bajo condiciones extremas de campo.